Date(s) - May 15,2021 - May 17,2021
8:00 am - 1:00 pm
Margaritaville Resort & Marina
HOTEL INFO: please call us to assist with room reservation
Margaritaville Resort and Marina now known as the Opal Key Resort and Marina
group rate $369 per night single, double, triple or quad occupancy. Rates are available to group 3 days pre and post, subject to availability. No resort fee.
Dr. William Benefield Jr., Pharm D., BCPP, FASCP
University of Texas at San Antonio and Austin
Dr. William Benefield graduated with honors from Auburn University with a BS in Pharmacy and received his Doctorate in Pharmacy degree from the University of Texas at Austin and the University of Texas Health Center at San Antonio. Dr. Benefield completed his residency in Psychiatric Pharmacy Practice at the University of Texas Health Science Center at San Antonio. He has been board certified in Psychiatric Pharmacy since 1997 and is a founding member of CPNP. He is currently a Clinical Assistant Professor of Psychiatry at the University of Texas. He has practiced in the areas of developmental disabilities, hospice and long term care for the past 27 years. He has authored and co-authored chapters in Pharmacotherapy, the Pharmacotherapy Case Book, and Applied Therapeutics. He has presented at the national meetings of the ACCP, ASCP, American Epilepsy Society, American Academy of Neurology, and NCDEU.
Saturday May 15, 2021
- Review and differentiate the various types of seizures and describe their presentation.
- Compare newer versus older anticonvulsants including their efficacy, pharmacology, and pharmacokinetic characteristics.
- Discuss the safety and tolerability of seizure management and understand how to select an appropriate therapeutic regimen in their management.
- Discuss the special considerations that must be addressed regarding drug interactions for a given anticonvulsant.
- Outline the potential benefits and risks of polytherapy versus monotherapy for patients with epilepsy.
- Review the nonpharmacological approaches to manage seizures
Sunday May 16, 2021
AUTISM AND OTHER PERVASIVE DEVELOPMENTAL DISORDERS
1. Review the clinical presentation of the major psychiatric disorders when presented with co-existing mental retardation.
2. Identify factors that may complicate recognition of a psychiatric disorder in the MR/DD population.
3. Discuss pharmacotherapy to manage the symptoms of the major psychiatric disorders presented in the MR/DD population.
4. Differentiate between the diagnostic criteria for autistic disorder and the other subtypes of pervasive developmental disorders.
5. Discuss the proposed pathophysiology and etiology within the pervasive disorder spectrum.
6. Identify target symptoms associated with pervasive developmental disorders which are responsive to pharmacotherapy.
7. Discuss the role of antipsychotics, antidepressants, mood stabilizers, alpha-adrenergic agonists, opiate agonists, and beta blockers in treating symptoms within the autistic disorder spectrum.
Monday May 17, 2021
- Review the clinical presentation of generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social phobia / social anxiety disorder.
- Identify the common comorbidities that may complicate recognition and management for each disorder.
- Discuss evidence-based approaches to manage the symptoms of each disorder.
- Strategize treatment via review of patient case studies
Don't have a Paypal account?
You do not need a Paypal Account to pay with Paypal. Paypal allows you to pay online simply by entering your credit card and billing information.